The aim of this work was to develop novel chitosan (CH) based nanoparticles (NPs) for rifampicin (RIF) delivery. RIF, a lipophilic molecule, was incorporated inside NPs as a complex with an anionic cyclodextrin, sulphobutylether-β-cyclodextrin (SBE-β-CD). NPs were then prepared through the ionic gelation method by exploiting the interaction between CH and SBE-β-CD-RIF complex (CH/SBE-β-CD-RIF NPs), possibly in the presence of other crosslinkers, like carboxymethylcellulose (CH/SBE-β-CD-RIF/CMC NPs) and pentasodium tripolyphosphate (CH/SBE-β-CD-RIF/TPP NPs). NPs were then characterized for their size, ζ-potential, morphology, yield, drug loading, stability, mucoadhesion, in vitro drug release and antimicrobial activity. Results demonstrated that the functional properties of loaded NPs, like their size, ζ-potential, and stability, varied on the basis of the CH/crosslinker weight ratio. Interestingly, all the developed NPs had a round shape and were characterized by high yield values and mucoadhesive properties. Among them, NPs based on CH/SBE-β-CD-RIF and CH/SBE-β-CD-RIF/CMC have gained high drug loading, provided a sustained release of RIF and showed the best antimicrobial activity. Thus, both types of NPs may be considered as promising nanocarriers for the release of RIF.

Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration

Angela Abruzzo;Vanessa Croatti;Giampaolo Zuccheri;Valentina Sallustio;Elisa Corazza;Beatrice Vitali;Teresa Cerchiara;Barbara Luppi;Federica Bigucci
2022

Abstract

The aim of this work was to develop novel chitosan (CH) based nanoparticles (NPs) for rifampicin (RIF) delivery. RIF, a lipophilic molecule, was incorporated inside NPs as a complex with an anionic cyclodextrin, sulphobutylether-β-cyclodextrin (SBE-β-CD). NPs were then prepared through the ionic gelation method by exploiting the interaction between CH and SBE-β-CD-RIF complex (CH/SBE-β-CD-RIF NPs), possibly in the presence of other crosslinkers, like carboxymethylcellulose (CH/SBE-β-CD-RIF/CMC NPs) and pentasodium tripolyphosphate (CH/SBE-β-CD-RIF/TPP NPs). NPs were then characterized for their size, ζ-potential, morphology, yield, drug loading, stability, mucoadhesion, in vitro drug release and antimicrobial activity. Results demonstrated that the functional properties of loaded NPs, like their size, ζ-potential, and stability, varied on the basis of the CH/crosslinker weight ratio. Interestingly, all the developed NPs had a round shape and were characterized by high yield values and mucoadhesive properties. Among them, NPs based on CH/SBE-β-CD-RIF and CH/SBE-β-CD-RIF/CMC have gained high drug loading, provided a sustained release of RIF and showed the best antimicrobial activity. Thus, both types of NPs may be considered as promising nanocarriers for the release of RIF.
Angela Abruzzo, Vanessa Croatti, Giampaolo Zuccheri, Fiore Pasquale Nicoletta, Valentina Sallustio, Elisa Corazza, Beatrice Vitali, Teresa Cerchiara, Barbara Luppi, Federica Bigucci
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/899865
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact